SPOTLIGHT -
Mother-to-child hepatitis b transmission presents economic trade-offs
Expanding peripartum prophylaxis could be more cost-effective, but would likely lead to significant over-treatment.
What's going on with polio, monkeypox, and COVID-19
The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?
FDA approves 20-valent pneumococcal conjugate vaccine for infants 6 weeks and older
According to Pfizer, the company’s pneumococcal conjugate vaccine Prevnar 20 has been approved by the FDA to treat infants and children aged 6 weeks to 17 years for the prevention of invasive pneumococcal disease (IPD).
What Omicron could mean for the pandemic
Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.
UNICEF flagship report highlights urgent need to resume child immunizations
The COVID-19 pandemic took a massive toll on routine vaccinations for children across the globe. Now, the United Nations Children’s Fund is calling for quick and swift action to get back on track.
FDA amends Moderna, Pfizer EUAs to simplify use of bivalent COVID-19 vaccines
Monovalent vaccines by these manufacturers are no longer authorized for use in the United States.
